PT3258960T - Proteínas imunoprotetoras de leptospira e métodos de identificação e sua utilização - Google Patents

Proteínas imunoprotetoras de leptospira e métodos de identificação e sua utilização

Info

Publication number
PT3258960T
PT3258960T PT167199496T PT16719949T PT3258960T PT 3258960 T PT3258960 T PT 3258960T PT 167199496 T PT167199496 T PT 167199496T PT 16719949 T PT16719949 T PT 16719949T PT 3258960 T PT3258960 T PT 3258960T
Authority
PT
Portugal
Prior art keywords
leptospira
identification
methods
immunoprotective proteins
immunoprotective
Prior art date
Application number
PT167199496T
Other languages
English (en)
Original Assignee
Pasteur Institut
Calixar
Vetagro Sup
Genostar
Boehringer Ingelheim Animal Health Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Calixar, Vetagro Sup, Genostar, Boehringer Ingelheim Animal Health Usa Inc filed Critical Pasteur Institut
Publication of PT3258960T publication Critical patent/PT3258960T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0208Specific bacteria not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
PT167199496T 2015-02-20 2016-02-22 Proteínas imunoprotetoras de leptospira e métodos de identificação e sua utilização PT3258960T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562118790P 2015-02-20 2015-02-20

Publications (1)

Publication Number Publication Date
PT3258960T true PT3258960T (pt) 2021-03-31

Family

ID=55863168

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167199496T PT3258960T (pt) 2015-02-20 2016-02-22 Proteínas imunoprotetoras de leptospira e métodos de identificação e sua utilização

Country Status (10)

Country Link
US (1) US10525117B2 (pt)
EP (1) EP3258960B1 (pt)
AU (1) AU2016219787B2 (pt)
CA (1) CA2977353A1 (pt)
DK (1) DK3258960T3 (pt)
ES (1) ES2864957T3 (pt)
HK (1) HK1248541A1 (pt)
NZ (1) NZ734938A (pt)
PT (1) PT3258960T (pt)
WO (1) WO2016134373A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230151064A1 (en) * 2020-02-07 2023-05-18 Yale University Leptospiral proteins and uses thereof
AU2022323324A1 (en) * 2021-08-06 2024-03-21 Yale University Leptospiral virulence modulating proteins and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
WO2004032599A2 (en) 2002-10-10 2004-04-22 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira
EP2205625B1 (en) 2007-09-24 2012-09-12 Cornell University Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon
CN101874898A (zh) 2010-06-21 2010-11-03 严杰 预防不同血清群问号钩端螺旋体感染的通用型三价基因重组疫苗及其制备方法

Also Published As

Publication number Publication date
DK3258960T3 (da) 2021-04-19
CA2977353A1 (en) 2016-08-25
ES2864957T3 (es) 2021-10-14
NZ734938A (en) 2019-06-28
AU2016219787A1 (en) 2017-09-14
US20170021004A1 (en) 2017-01-26
AU2016219787B2 (en) 2019-05-30
EP3258960B1 (en) 2021-01-13
HK1248541A1 (zh) 2018-10-19
WO2016134373A3 (en) 2016-11-10
EP3258960A2 (en) 2017-12-27
US10525117B2 (en) 2020-01-07
WO2016134373A2 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
HK1257310A1 (zh) 抗-cd47抗體及使用方法
HK1249445A1 (zh) 抗分揀蛋白抗體和其使用方法
HK1252698A1 (zh) 抗siglec-9抗體及其使用方法
IL259495A (en) Antibodies and methods for using them
HK1252696A1 (zh) 抗siglec-7抗體及其使用方法
IL246921B (en) Binding proteins and their uses
SG10201912150TA (en) Anti-trem2 antibodies and methods of use thereof
ZA202001985B (en) Anti-htra1 antibodies and methods of use thereof
IL282482A (en) Variants of protoxin-II and methods of use
IL282508A (en) Variants of protoxin-II and methods of use
HK1248541A1 (zh) 鉤端螺旋體免疫防護蛋白及其鑒定和使用方法
GB201501469D0 (en) Garment and method of use thereof